[1] CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. [2] FAKHRIAN K, ORDU A D, LORDICK F, et al. Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years' experience at a single institution[J]. Et Al, 2014, 190(12): 1133-1140. [3] SANGER H L, KLOTZ G, RIESNER D, et al. Viroids are singlestranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures[J]. Proc Natl Acad Sci USA, 1976, 73(11): 3852-3856. [4] MEMCZAK S, JENS M, ELEFSINIOTI A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency[J]. Nature, 2013, 495(7441): 333-338. [5] JECK W R, SORRENTINO J A, WANG K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats[J]. RNA, 2013, 19(2): 141-157. [6] HAN D, WANG Y, WANG Y, et al. The tumor-suppressive human circular RNA CircITCH sponges miR-330-5p to ameliorate doxorubicin-induced cardiotoxicity through upregulating SIRT6, survivin, and SERCA2a[J]. Circ Res, 2020, 127(4): e108-e125. [7] FENG Q Q, ZHANG H L, YAO D L, et al. Emerging role of non-coding RNAs in esophageal squamous cell carcinoma[J]. Int J Mol Sci, 2019, 21(1): E258. [8] LEGNINI I, DI TIMOTEO G, ROSSI F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis[J]. Mol Cell, 2017, 66(1): 22-37.e9. [9] HANG D, ZHOU J, QIN N, et al. A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer[J]. Cancer Med, 2018, 7(6): 2783-2791. [10] 杨春梅, 乔光磊, 宋丽娜, 等. 血浆has-circ-0003998在原发性肝细胞癌诊断和预后评估中的临床价值[J]. 中国实验诊断学, 2019, 23(5): 761-766. [11] 宋丽娜, 顾芳芳, 杨诚, 等. Has-circ-0008934在原发性肝细胞癌诊断和预后评估中的临床价值[J]. 中国实验诊断学, 2020, 24(5): 713-717. [12] SHANG X C, LI G Z, LIU H, et al. Comprehensive circular RNA profiling reveals that has-circ-0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development[J]. Medicine (Baltimore), 2016, 95(22): e3811. [13] XIA W J, QIU M T, CHEN R, et al. Circular RNA has-circ-0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation[J]. Sci Rep, 2016, 6: 35576. [14] SANG M X, MENG L J, SANG Y, et al. Circular RNA ciRS-7 accelerates ESCC progression through acting as a miR-876-5p sponge to enhance MAGE-A family expression[J]. Cancer Lett, 2018, 426: 37-46. [15] LI R C, KE S, MENG F K, et al. CiRS-7 promotes growth and metastasis of esophageal squamous cell carcinoma via regulation of miR-7/HOXB13[J]. Cell Death Dis, 2018, 9(8): 838. [16] HUANG H R, WEI L, QIN T, et al. Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7/KLF4 and NF-κB signals[J]. Cancer Biol Ther, 2019, 20(1): 73-80. [17] 胡学廷, 姜明, 郑泽华, 等. 环状RNA circPRDM5在食管鳞状细胞癌中的表达和功能研究[J]. 岭南现代临床外科, 2019, 19(2): 139-144. [18] ZHENG B, WU Z G, XUE S T, et al. has-circRNA-100873 upregulation is associated with increased lymphatic metastasis of esophageal squamous cell carcinoma[J]. Oncol Lett, 2019, 18(6): 6836-6844. [19] CAO S, CHEN G H, YAN L M, et al. Contribution of dysregulated circRNA-100876 to proliferation and metastasis of esophageal squamous cell carcinoma[J]. Onco Targets Ther, 2018, 11: 7385-7394. [20] HU X T, WU D G, HE X T, et al. circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling [J]. Mol Cancer, 2019, 18(1): 160. [21] LIU J Q, XUE N N, GUO Y X, et al. CircRNA-100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway[J]. Aging (Albany NY), 2019, 11(24): 12412-12427. [22] SHI Y J, GUO Z Z, FANG N, et al. has-circ-0006168 sponges miR-100 and regulates mTOR to promote the proliferation, migration and invasion of esophageal squamous cell carcinoma[J]. Biomed Pharmacother, 2019, 117: 109151. [23] PAN Z H, LIN J T, WU D G, et al. Has-circ-0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma[J]. Aging (Albany NY), 2019, 11(24): 11937-11954. [24] ZHONG R R, CHEN Z Z, MO T, et al. Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma[J]. Cancer Cell Int, 2019, 19: 267. [25] SONG H, XU D, SHI P, et al. Upregulated circ RNA has-circ-0000337 promotes cell proliferation, migration, and invasion of esophageal squamous cell carcinoma[J]. Cancer Manag Res, 2019, 11: 1997-2006. [26] WANG Q, ZHANG Q, SUN H D, et al. Circ-TTC17 promotes proliferation and migration of esophageal squamous cell carcinoma[J]. Dig Dis Sci, 2019, 64(3): 751-758. [27] RONG J, WANG Q, ZHANG Y Z, et al. Circ-DLG 1 promotes the proliferation of esophageal squamous cell carcinoma[J]. Oncotargets Ther, 2018, 11: 6723-6730. [28] SHI N M, SHAN B, GU B, et al. Circular RNA circ-PRKCI functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-3680-3p in esophageal squamous cell carcinoma[J]. J Cell Biochem, 2019, 120(6): 10021-10030. [29] XU Z, TIE X, LI N, et al. Circular RNA has-circ-0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway[J]. IUBMB Life, 2020, 72(3): 426-439. [30] SHI Y J, FANG N, LI Y D, et al. Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis[J]. Cancer Sci, 2020, 111(8): 2824-2836. [31] ZHANG Z, LI X, XIONG F, et al. Has-circ-0012563 promotes migration and invasion of esophageal squamous cell carcinoma by regulating XRCC1/EMT pathway[J]. J Clin Lab Anal, 2020, 34(8): e23308. [32] WANG C X, TANG D R, WANG H Y, et al. Circular RNA has-circ-0030018 Acts as a sponge of miR-599 to aggravate esophageal carcinoma progression by regulating ENAH expression[J]. J Cell Biochem, 2019: 1-9. [33] HUANG E M, FU J H, YU Q Y, et al. CircRNA has-circ-0004771 promotes esophageal squamous cell cancer progression via miR-339-5p/CDC25A axis[J]. Epigenomics, 2020, 12(7): 587-603. [34] ZHANG Y, TANG Q, HUANG X M, et al. Circular RNA circCNOT6L regulates cell development through modulating miR-384/FN1 axis in esophageal squamous cell carcinoma[J]. Eur Rev Med Pharmacol Sci, 2020, 24(7): 3674-3685. [35] WANG Q, LIU H, LIU Z H, et al. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC[J]. Cancer Genet, 2020, 240: 33-39. [36] HOU Y, LIU H, PAN W D. Knockdown of circ-0003340 induces cell apoptosis, inhibits invasion and proliferation through miR-564/TPX2 in esophageal cancer cells[J]. Exp Cell Res, 2020, 394(2): 112142. [37] WU Y, ZHI L R, ZHAO Y, et al. Knockdown of circular RNA UBAP2 inhibits the malignant behaviours of esophageal squamous cell carcinoma by microRNA-422a/Rab10 axis[J]. Clin Exp Pharmacol Physiol, 2020, 47(7): 1283-1290. [38] LI F, ZHANG L Y, LI W, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway[J]. Oncotarget, 2015, 6(8): 6001-6013. [39] HE Y L, MINGYAN E, WANG C B, et al. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway[J]. Int J Biol Macromol, 2019, 125: 116-123. [40] CHEN Z M, YAO N H, GU H M, et al. Circular RNA_LARP4 sponges miR-1323 and hampers progression of esophageal squamous cell carcinoma through modulating PTEN/PI3K/AKT pathway[J]. Dig Dis Sci, 2020, 65(8): 2272-2283. [41] WANG W, MA J, LU J, et al. Circ0043898 Acts as a tumor inhibitor and performs regulatory effect on the inhibition of esophageal carcinoma [J]. Cancer Biol Ther, 2018, 19(12): 1117-1127. [42] ZHANG Y Z, WANG Q, ZHU D L, et al. Up-regulation of circ-SMAD7 inhibits tumor proliferation and migration in esophageal squamous cell carcinoma[J]. Biomedecine Pharmacother, 2019, 111: 596-601. [43] KEFAS B, GODLEWSKI J, COMEAU L, et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is downregulated in glioblastoma[J]. Cancer Res, 2008, 68(10): 3566-3572. [44] FANG Y X, XUE J L, SHEN Q, et al. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma[J]. Hepatology, 2012, 55(6): 1852-1862. |